Figures & data
Table 1 Demographic and clinical characteristics of patients at baseline
Figure 1 Mean 17-item Hamilton Rating Scale for Depression (HAMD-17) total score during the 8-week treatment period.
Figure 2 Proportions of patients showing response to treatment (responders: HAMD-17 total score decreased by ≥50% from baseline) and remission (remitters: HAMD-17 total score <7 during the treatment period, indicating they were free from depression) during the 8-week treatment period.
Figure 3 Mean single Hamilton Rating Scale for Depression item scores for “work and activities” (item 7) and “psychomotor retardation” (item 8) during the 8-week treatment period.
Abbreviation: HAMD-17, 17-item Hamilton Rating Scale for Depression.
Figure 4 Upper panel: frequency distribution of Clinical Global Impression Severity Scale (CGI-S) scores after 8 weeks of treatment.
Figure 5 Subgroup of more severely ill patients. Proportions of patients showing response to treatment (responders: HAMD-17 total score decreased by ≥50% from baseline) and remission (remitters: HAMD-17 total score <7 during the treatment period, indicating they were free from depression) in the subgroup of patients (n=3,478) with HAMD-17 total score ≥21 at baseline.
Table 2 Adverse events reported by ≥0.25% of patients